USANA Health Sciences, Inc. (USNA)

USANA Health Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 27, 2025	Dec 28, 2024	Dec 30, 2023	Dec 31, 2022	Jan 1, 2022	Jan 2, 2021
Net Income	16.99	42.03	63.79	69.35	116.51	124.66
Depreciation & Amortization	35.3	22.23	20.4	21.41	22.19	22.51
Loss (Gain) From Sale of Assets	0.12	0	0.01	0.14	0.06	0.19
Asset Writedown & Restructuring Costs	-	-	-	-	-	0.51
Stock-Based Compensation	13.69	14.56	14.6	13.33	14.3	14.39
Other Operating Activities	-4.18	-4.82	-0.15	-1.1	1.23	-2.42
Change in Inventory	-19.47	-2.12	2.35	15.8	-14.7	-16.78
Change in Accounts Payable	5.91	-1.27	-0.43	-2.66	-4.57	6.08
Change in Other Net Operating Assets	-16.84	-9.62	-29.92	-12.37	-13.79	11.26
Operating Cash Flow	31.52	60.99	70.64	103.9	121.23	160.4
Operating Cash Flow Growth	-61.19%	-13.66%	-32.01%	-14.29%	-24.42%	26.57%
Capital Expenditures	-12.83	-10.07	-14.49	-10.4	-12.76	-15.09
Sale of Property, Plant & Equipment	-	0.06	0.02	0.01	0.02	0.01
Cash Acquisitions	-203.34	-203.34	-	-6.53	-	-
Investment in Securities	-	-	-	-	-	-20
Other Investing Activities	-0.21	0.26	2.5	4.56	-1.44	1.13
Investing Cash Flow	-216.37	-213.09	-11.98	-12.37	-14.19	-33.96
Short-Term Debt Issued	-	23.69	1.54	11	-	60
Total Debt Issued	24.6	23.69	1.54	11	-	60
Short-Term Debt Repaid	-	-1.47	-0.75	-11	-	-60
Total Debt Repaid	-24.59	-1.47	-0.75	-11	-	-60
Net Debt Issued (Repaid)	0	22.22	0.79	-	-	-
Repurchase of Common Stock	-29.87	-12.67	-14.69	-30.09	-181.41	-59.4
Other Financing Activities	-1.26	-	-0.34	-	-	-0.05
Financing Cash Flow	-31.13	9.55	-14.24	-30.09	-181.41	-59.44
Foreign Exchange Rate Adjustments	-3.61	-6.19	-2.5	-13.78	2.09	11.25
Net Cash Flow	-219.59	-148.74	41.93	47.67	-72.28	78.25
Free Cash Flow	18.69	50.92	56.15	93.5	108.46	145.31
Free Cash Flow Growth	-71.52%	-9.31%	-39.95%	-13.79%	-25.36%	31.90%
Free Cash Flow Margin	2.05%	5.96%	6.10%	9.36%	9.14%	12.81%
Free Cash Flow Per Share	0.99	2.66	2.90	4.84	5.33	6.84
Cash Interest Paid	0.67	0.08	0.07	0.05	0.01	0.71
Cash Income Tax Paid	38.5	40.4	42.33	45.75	59.33	52.17
Levered Free Cash Flow	33.46	57.95	61.35	104.19	112.81	144.8
Unlevered Free Cash Flow	33.99	58.13	61.51	104.31	112.84	145.12
Change in Working Capital	-30.41	-13	-28	0.77	-33.06	0.56

Updated Oct 22, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q